Jean Witz Joins Wilson Sonsini as Senior Patent Counsel, Bolstering Firm's Expertise in Biotechnology and Pharmaceuticals

Jean Witz, with nearly 40 years of experience in patent law and a distinguished career at the USPTO, joins Wilson Sonsini as senior patent counsel, enhancing the firm's capabilities in biotechnology, pharmaceuticals, and chemical engineering.

June 4, 2025
Jean Witz Joins Wilson Sonsini as Senior Patent Counsel, Bolstering Firm's Expertise in Biotechnology and Pharmaceuticals

Wilson Sonsini Goodrich & Rosati has announced the addition of Jean Witz as senior patent counsel in its Washington, D.C., office. Witz's extensive experience at the United States Patent and Trademark Office (USPTO), particularly in biotechnology, pharmaceuticals, and chemical patent reexaminations, positions her as a valuable asset to the firm and its clients. Her deep understanding of the USPTO's operations and decision-making processes is expected to provide significant advantages in navigating complex intellectual property challenges.

Witz's career highlights include her role as a supervisory patent reexamination specialist in the USPTO’s Central Reexamination Unit, where she led a team reviewing reexamination requests in key scientific fields. Her work in developing examiner training programs and her contributions to resolving complex patent disputes underscore her expertise and leadership in the field. Witz's academic background in biology and her teaching experience further complement her professional achievements, making her a well-rounded addition to Wilson Sonsini.

The implications of Witz's joining Wilson Sonsini are significant for the firm's clients, especially those in the life sciences sector. Her insight into the USPTO's examination process and her ability to anticipate and address potential challenges in patent applications and disputes will be invaluable. This move not only strengthens Wilson Sonsini's position as a leader in intellectual property law but also highlights the growing importance of specialized legal expertise in the rapidly evolving fields of biotechnology and pharmaceuticals.